GPBAR1 and obesity disorder: Ursolic acid acts by activating the membrane receptor TGR5, which is linked to the management and prevention of several metabolic syndromes such as diabetes, obesity or fatty liver [75,77], as it regulates insulin sensitivity, in addition to several processes related to lipid metabolism, glucose homeostasis, and energy expenditure [15,75].